CLOV vs MGNX · rev $1.37B vs rev $149.5M
Clover Health Investments Corp (CLOV) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported MGNX revenue for 2025-12-31 was $149.5M. Net income was -$74.6M. Revenue was down 0.3% from 2024-12-31 to 2025-12-31. MGNX currently screens at market cap $246.6M.
CLOV currently screens at market cap $1.55B. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the CLOV and MGNX stock pages for the full models.
Not investment advice.